SCHEMBL30142947

SCHEMBL30142947

Nc1cnn(C2CC2(F)F)c1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.31
LMNA P02545 1/20 0.31
ALDH1A1 P00352 1/20 0.30
PKM P14618 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23612150 0.79 KDM5A (0.36) MAPTLMNA
SCHEMBL31131563 0.77 F2 (0.30)
SCHEMBL26388614 0.77 MPO (0.44)
SCHEMBL28321758 0.74 KDM5A (0.35)
SCHEMBL26500110 0.74 KDM5A (0.34)
SCHEMBL30911790 0.73 TRPC3 (0.30)
SCHEMBL28859329 0.72 KDM5A (0.36) LMNAALDH1A1
SCHEMBL173506 0.71
Hydrochloric Acid SCHEMBL31507950 0.69 PIK3CD (0.41) MAPTLMNA
Hydrochloric Acid SCHEMBL25243994 0.69 PIK3CD (0.41) MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230014226-A1 NEW COMPOUNDS AND METHODS BENEVOLENTAI BIO LIMITED (GB) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014226-A1 NEW COMPOUNDS AND METHODS ABL2, ABL1, ALK MAPT 23/4885LMNA 1857/4885ALDH1A1 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.